What's on this Page
What is Rilonacept
Rilonacept (Arcalyst™, Interleukin-1 Trap) is an interleukin-1 inhibitor that is the first FDA-approved treatment for cryopyrin-associated periodic syndromes (CAPS) including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS) in adults and children at least 12 years of age. Cryopyrin-associated periodic syndromes is a spectrum of rare, inherited autoinflammatory conditions.
The autoinflammatory diseases are characterized by spontaneous and environmentally triggered systemic inflammation. Symptoms may include fever, chills, rash, fatigue, joint pain, and eye redness.
Symptoms of CAPS are hard to treat; corticosteroids may provide limited relief. Long-term sequelae of CAPS may include amyloidosis and neurologic/intellectual impairment. In a study, 160 mg SC once weekly to patients with either FCAS or MWS led to significant improvement in the disease activity score as compared with scores from placebo recipients.
Also, rilonacept recipients had a 93% reduction in their serum amyloid A concentration whereas placebo recipients had a 0% change.
Continued rilonacept receipt for 9 weeks maintained the reduced disease activity score and serum amyloid A concentration. In contrast, rilonacept cessation led to an increased disease activity score and serum amyloid A concentration.
Rilonacept was FDA approved in February 2008.
Brand Name
Arcalyst
Indications
- cryopyrin-associated periodic syndromes (CAPS)
For the treatment of cryopyrin-associated periodic syndromes (CAPS) including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS)
Side Effects
- antibody formation
- bleeding
- cough
- ecchymosis
- edema
- erythema
- hypercholesterolemia
- hypertriglyceridemia
- infection
- injection site reaction
- new primary malignancy
- pruritus
- rash
- sinusitis
- urticaria
Monitoring Parameters
- serum lipid profile
- serum triglycerides
Contraindications
- acquired immunodeficiency syndrome (AIDS)
- asthma
- bone marrow suppression
- breast-feeding
- children
- diabetes mellitus
- geriatric
- hamster protein hypersensitivity
- hepatitis
- human immunodeficiency virus (HIV) infection
- hypercholesterolemia
- hypertriglyceridemia
- immunosuppression
- infants
- infection
- intramuscular administration
- intravenous administration
- neonates
- pregnancy
- tuberculosis
- vaccination
Interactions
- Adalimumab
- Anakinra
- Antithymocyte Globulin
- Azathioprine
- Bacillus Calmette-Guerin Vaccine, BCG
- Basiliximab
- Canakinumab
- Certolizumab pegol
- Cyclophosphamide
- Cyclosporine
- Dexamethasone
- Efalizumab
- Etanercept
- Golimumab
- Infliximab
- Influenza Virus Vaccine
- Intranasal Influenza Vaccine
- Live Vaccines
- Measles Virus; Mumps Virus; Rubella Virus; Varicella Virus Vaccine, Live
- Measles/Mumps/Rubella Vaccines, MMR
- Methotrexate
- Methylprednisolone
- Muromonab-CD3
- Prednisone
- Rotavirus Vaccine
- Rubella Virus Vaccine Live
- Smallpox and Monkeypox Vaccine, Live, Nonreplicating
- Smallpox Vaccine, Vaccinia Vaccine
- Tumor Necrosis Factor modifiers
- Typhoid Vaccine
- Varicella-Zoster Virus Vaccine, Live
- Warfarin
- Yellow Fever Vaccine, Live
